Laminin inhibits A β42 fibril formation in vitro

Brain Research

Volumn 788, Issue 1-2, 1998, Pages 187-190

  Monji, Akira ^a   Tashiro, Ken Ichiro ^b   Yoshida, Ichiro ^a   Hayashi, Yoshihito ^b   Tashiro, Nobutada ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

A 42; Alzheimer's disease; Electron microscopy; Laminin; Thioflavine T fluorescence

Indexed keywords

AMYLOID BETA PROTEIN; LAMININ; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; ELECTRON MICROSCOPY; FLUOROMETRY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; IN VITRO STUDY; METABOLISM; MOUSE;

AMYLOID BETA-PROTEIN; ANIMALS; LAMININ; MICE; MICROSCOPY, ELECTRON; PEPTIDE FRAGMENTS;

EID: 0032579609     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01542-4     Document Type: Article

References (21)

1. Aksenova M.V., Aksenov M.Y., Butterfield D.A., Carney J.M. α-1-antichymotrypsin interaction with Aβ(1-40) inhibits fibril formation but does not affect the peptide toxicity. Neurosci. Lett. 211:1996;45-48.
2. Aksenov M.Y., Aksenova M.Y., Butterfield D.A., Hensley K., Vigo-Pelfrey C., Carney J.M. Glutamate synthetase-induced enhancement of β-amyloid peptide Aβ(1-40) neurotoxicity accompanied by abrongation of fibril formation and Aβ fragmentation. J. Neurochem. 66:1996;2050-2056.
3. Aksenov M.Y., Aksenova M.V., Carney J.M., Butterfield D.A. α-1-antichymotrypsin interaction with Aβ(1-42) does not inhibit fibril formation but attenuates the peptide toxicity. Neurosci. Lett. 217:1996;117-120.
4. Bronfman F.C., Garrido J., Alvarez A., Morgan C., Inestrosa N.C. Laminin inhibits amyloid-β-peptide fibrillation. Neurosci. Lett. 218:1996;201-203.
5. Bronfman F.C., Soto C., Tapia L., Tapia V., Inestrosa N.C. Extracellular matrix regulates the amount of the β-amyloid precursor protein and its amyloidogenic fragments. J. Cell. Physiol. 166:1996;360-369.
6. Busciglio J., Lorenzo A., Yeh J., Yanker B.A. β-Amyloid fibrils induce tau phosphorylation and microtubule binding. Neuron. 14:1995;879-888.
7. Eriksson S., Janciauskiene S., Lannfelt L. α1-antichymotrypsin regulates Alzheimer β amyloid fibril formation. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2313-2317.
8. Ishii K., Tamaoka A., Mizusawa H., Shoji H., Ohtake T., Fraser P.E., Takahashi H., Tuji S., Gearing M., Mizutani T., Yamada S., Kato M., St-George-Hyslop P.H., Mirra S.S., Mori H. Aβ1-40 but not Aβ1-42 levels in cortex correlate with apolipoprotein E ε4 allele dosage in sporadic Alzheimer's disease. Brain Res. 748:1997;250-252.
9. Janciauskiene S., Garcia de Frutos P., Carlemalm E., Dahlback B., Eriksson S. Inhibition of Alzheimer β-peptide fibril formation by serum amyloid P component. J. Biol. Chem. 270:1995;26041-26044.
10. Jarret J.T., Lansbury P.T. Seeding 'one-dimensional crystallization' of amyloid: a pathogenetic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058.
11. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:1993;76-83.
12. Lorenzo A., Yanker B. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12243-12247.
13. Murtomaki S., Risteri J., Risteri L., Koivisto U.M., Johansson S., Liesi P. Laminin and its neurite outgrowth-promoting domain in the brain of Alzheimer's disease and Down's syndrome patients. J. Neurosci. Res. 32:1992;261-273.
14. 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136:1995;22-31.
15. Salomon A.R., Marcinowski K.J., Friedland R.P., Zagorski M.G. Nicotine inhibits amyloid formation by the β-peptide. Biochemistry. 35:1996;13568-13578.
16. Selkoe D.J. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
17. Shin R.W., Ogino K., Kondo A., Saido T., Trowjanowski J.Q., Kitamoto T., Tateishi J. Amyloid β-protein (Aβ) 1-40 but not Aβ1-42 contributes to the experimental formation of Alzheimer's disease amyloid fibrils in rat brain. J. Neurosci. 17:1997;8187-8193.
18. Timpl R., Brown C.J. The laminins. Matrix Biol. 14:1994;275-281.
19. Tomiyama K., Asano S., Suwa Y., Morita T., Kataoka K., Mori H., Endo N. Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem. Biophys. Res. Commun. 204:1994;76-83.
20. Wood S.J., MacKenzie L., Maleeff B., Hurle M.R., Wetzel R. Selective inhibition of Aβ fibril formation. J. Biol. Chem. 271:1996;4086-4092.
21. Yanker B.A. Mechanism of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.